AUPH - Aurinia Pharma GAAP EPS of -$0.25 beats by $0.02 revenue of $23.4M beats by $1.57M February, 28 2022 06:00 AM Aurinia Pharmaceuticals Inc Aurinia Pharma press release (NASDAQ:AUPH): Q4 GAAP EPS of -$0.25 beats by $0.02. Revenue of $23.4M (-53.2% Y/Y) beats by $1.57M. For further details see: Aurinia Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $23.4M beats by $1.57M